We are live on ! Find out more
JNJ icon

Johnson & Johnson

2,233 hedge funds and large institutions have $221B invested in Johnson & Johnson in 2016 Q2 according to their latest regulatory filings, with 98 funds opening new positions, 868 increasing their positions, 1,042 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

96% more first-time investments, than exits

New positions opened: 98 | Existing positions closed: 50

14% more capital invested

Capital invested by funds: $194B → $221B (+$26.9B)

13% more funds holding in top 10

Funds holding in top 10: 756856 (+100)

1% more funds holding

Funds holding: 2,2042,233 (+29)

7% less call options, than puts

Call options by funds: $2.12B | Put options by funds: $2.28B

2.28% less ownership

Funds ownership: 68.63%66.35% (-2.3%)

17% less repeat investments, than reductions

Existing positions increased: 868 | Existing positions reduced: 1,042

Holders
2,233
Holders Change
+29
Holders Change %
+1.32%
% of All Funds
59.56%
Holding in Top 10
856
Holding in Top 10 Change
+100
Holding in Top 10 Change %
+13.23%
% of All Funds
22.83%
New
98
Increased
868
Reduced
1,042
Closed
50
Calls
$2.12B
Puts
$2.28B
Net Calls
-$160M
Net Calls Change
-$455M
Name Holding Trade Value Shares
Change
Change in
Stake
WIC
1151
Whitegate Investment Counselors
New Hampshire
$4.89M +$4.58M +40,346 New
FA
1152
FCG Advisors
New Jersey
$4.89M +$104K +916 +2%
LIM
1153
Leavell Investment Management
Alabama
$4.88M -$29K -255 -0.6%
BSPF
1154
British Steel Pension Fund
United Kingdom
$4.88M -$3.46M -30,451 -43%
HAM
1155
Highstreet Asset Management
Ontario, Canada
$4.86M +$273K +2,406 +6%
CVSCT
1156
C.V. Starr & Co Trust
New York
$4.85M -$4.55M -40,000 -50%
SGH
1157
Sivik Global Healthcare
Connecticut
$4.85M +$4.55M +40,000 New
HI
1158
Hendershot Investments
Virginia
$4.85M -$46.6K -410 -1%
WA
1159
WBH Advisory
Maryland
$4.84M -$283K -2,493 -6%
CCA
1160
Catalyst Capital Advisors
New York
$4.83M +$3.06M +26,900 +209%
GI
1161
Gradient Investments
Minnesota
$4.81M +$293K +2,582 +7%
CIS
1162
Capital International Sarl
California
$4.79M +$4.49M +39,500 New
SGCA
1163
Steel Grove Capital Advisors
Tennessee
$4.78M +$75.3K +663 +2%
EFIC
1164
Eliot Finkel Investment Counsel
California
$4.75M -$223K -1,960 -5%
ATC
1165
Argent Trust Co
Tennessee
$4.74M +$27K +238 +0.6%
SWM
1166
Segment Wealth Management
Texas
$4.74M -$313K -2,755 -7%
ACM
1167
Alpha Capital Management
Texas
$4.73M -$173K -1,520 -4%
SIM
1168
Sonora Investment Management
Arizona
$4.73M +$9.54K +84 +0.2%
RCAG
1169
Rehmann Capital Advisory Group
Michigan
$4.69M +$10K +88 +0.2%
AIM
1170
Anchor Investment Management
South Carolina
$4.69M +$8.29K +73 +0.2%
FCH
1171
Freestone Capital Holdings
Washington
$4.68M +$291K +2,558 +7%
IMOV
1172
Investment Management of Virginia
Virginia
$4.68M -$119K -1,045 -3%
NG
1173
Northstar Group
New York
$4.67M -$38.2K -336 -0.9%
PWAP
1174
Private Wealth Advisors (Pennsylvania)
Pennsylvania
$4.67M -$10.9K -96 -0.2%
BCCM
1175
Bridge Creek Capital Management
Massachusetts
$4.66M -$91.5K -805 -2%

JNJ Hedge Fund Activity: Q2 2016 in Review

2,233 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q2 2016, worth a combined $221B — up 14% from $194B a quarter earlier.

Buyers outnumbered sellers: 98 funds opened new JNJ positions and 50 closed out — a net gain of 48 holders — while 868 added to existing stakes and 1,042 trimmed.

The largest buyer was Macquarie Group, adding an estimated $723M. The largest seller was Royal London Asset Management, cutting an estimated $8.14B.

  • 2,233 institutional investors held Johnson & Johnson (JNJ) as of Q2 2016, up from 2,204 in Q1 2016.
  • Funds reported $221B of Johnson & Johnson stock for Q2 2016, up 14% quarter-over-quarter.
  • 98 funds opened new Johnson & Johnson positions in Q2 2016 and 50 closed out, a net change of +48 holders.
  • The largest Johnson & Johnson buyer in Q2 2016 was Macquarie Group, an estimated $723M added.
  • The largest Johnson & Johnson seller in Q2 2016 was Royal London Asset Management, an estimated $8.14B sold.

Based on aggregated 13F filings for Q2 2016.